MEGA LIFESCIENCES |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.5 THB | -1.22% |
|
-1.82% | +0.62% |
Presenter SpeechVivek Dhawan (Executives)[Foreign Language] I'm Vivek Dhawan, CEO of Mega Life...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
40.5
THB
Average target price
49.56
THB
Spread / Average Target
+22.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.62% | 957M | |
| +26.09% | 681B | |
| +21.85% | 556B | |
| -5.27% | 361B | |
| +17.22% | 325B | |
| +4.74% | 285B | |
| +13.68% | 235B | |
| +3.65% | 199B | |
| -11.12% | 189B | |
| -4.06% | 157B |
- Stock Market
- Equities
- MEGA Stock
- News Mega Lifesciences
- Transcript : Mega Lifesciences Public Company Limited, Q3 2022 Earnings Call, Nov 15, 2022
